Skip to content

Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge Reader

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the broadening of the intellectual property portfolio of its wholly owned subsidiary, Intelligent Fingerprinting Limited, with the grant of a new European patent with unitary effect for its ground-breaking DSR-Plus Cartridge Reader. This latest achievement follows the successful protection of the same technology in the United Kingdom and marks another significant milestone in the Company’s expansion and protection of its intellectual property. Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge Reader

ICTRP searches: dispensable for drug assessment

  • News

Regular searches in the ICTRP portal for studies on non-drug interventions are important, but searches for drug studies offer little added value there. This is shown by an IQWiG analysis.

Researchers develop a method to extract useful proteins from beer-brewing leftovers

Researchers from Nanyang Technological University, Singapore (NTU Singapore), have created a method that extracts over 80 per cent of the available protein in grain leftovers from brewing beer, commonly known as brewers’ spent grain. Brewers’ spent grain (BSG) is the solid residue from malted barley after brewing beer. It is the most significant byproduct of the beer brewing industry, making up 85 per cent of the total waste. Globally, about 36.4 million tons of spent grain are produced every year. The proteins extracted by the NTU researchers were found to be rich in antioxidants, which could not only protect human skin from pollutants but could also extend the shelf life of cosmetics like body lotions and moisturisers. This could present an eco-friendly alternative to conventional cosmetic components such as parabens, which disrupt hormone function in aquatic organisms, and petroleum-based ingredients,… 

Advances in brain organoids from the lab

An artificial brain from the lab may sound like pure science fiction, but a Japanese-French research team has now actually developed a technique to connect lab-grown brain-like tissues. In a study in the journal Nature Communications, they compare their structure to the neural circuits in the human brain. Lab cultivation of brain cells The researchers at the Institute of Industrial Science […] Advances in brain organoids from the lab

Advances in research and development: Enrollment of subjects in the Phase III clinical trial for inhalation sprays in children by Kexing Biopharm

  • News

Shenzhen, China (ots/PRNewswire) – Kexing Biopharm (688136.SH) recently announced that the Phase III clinical trial for the inhaled solution of human interferon ?1b, developed by its wholly-owned subsidiary Shenzhen Kexing Pharmaceutical Co., Ltd., has completed the enrollment and dosing of the first patient. This drug is used in children for lower respiratory tract infections (pneumonia, bronchiolitis) […] R&D Progress: Kexing Biopharm Enrolls First Patient in Phase III Clinical Trial of Inhaled Spray for Children

Geriatrics: Florence Charter Published

  • News

The Menarini Foundation, at the forefront of the fight against discrimination in healthcare for the elderly, contributed to the development of the Florence Charter. The Florence Charter, presented at the "Anti-Ageism Alliance" congress held under the auspices of the Italian Society of Gerontology and Geriatrics, the International Association of Gerontology & Geriatrics, and the European Geriatric Medicine Society, is the first global manifesto against ageism in healthcare. The document, drafted by leading global experts, including WHO representatives, and coordinated by Andrea Ungar, Professor of Geriatrics at the University of Florence, published in the journal European Geriatric Medicine, outlines 12 concrete actions to combat age-related biases in healthcare and improve the quality and duration of life for older people.

Tsingke Presents Forward-Looking Biologics Solutions at Biologics 2024

  • News

Beijing and Paris (ots/PRNewswire) – On March 15, Biologics 2024 in London successfully concluded. A total of 650 representatives from the pharmaceutical, biotechnology, and scientific fields, along with over 50 exhibitors, engaged in high-level discussions on the latest innovations in biologics research and development. As a pioneer in DNA/RNA synthesis technology, Tsingke was honored to […] Tsingke Presents Forward-Looking Biologics Solutions at Biologics 2024